Results 1 to 10 of about 304,324 (330)

Systemic Lupus Erythematosus [PDF]

Clinical and Developmental Immunology, 2012
Systemic lupus erythematosus (SLE) is the prototypical autoimmune disease, associated with autoantibody production and evidence for immune complex deposition among the many aspects of its pathophysiology. SLE occurs most commonly in women during their reproductive years.
Anne Davidson, Roberto Caricchio, Harris Perlman, Chaim Putterman   +3 more
  +12 more sources

Systemic lupus erythematosus [PDF]

Orphanet Journal of Rare Diseases, 2006
Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease, which is autoimmune in origin and is characterized by the presence of autoantibodies directed against nuclear antigens. It is a multi-system disease, and patients can present in vastly different ways.
Anisur Rahman, Jessica J Manson
  +11 more sources

Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study

Annals of the Rheumatic Diseases, 2022
Objectives To quantify global, regional and country-specific estimates of epidemiology of systemic lupus erythematosus (SLE). Methods Four databases were systematically searched, and a Bayesian hierarchical linear mixed model was constructed to estimate ...
Jingru Tian, Dingyao Zhang, X. Yao, Yaqing Huang, Q. Lu   +4 more
semanticscholar   +1 more source

Systemic Lupus Erythematosus [PDF]

Cell, 1996
Systemic Lupus Erythematosus (SLE) of childhood is a complex and challenging disease which can occur at any age. Identification of disease early in it's course and aggressive, appropriate management leads to improved outcome for an individual child. The history of SLE indicates how much progress has been made in the last quarter century.
Marisa S. Klein-Gitelman, Michael L. Miller   +1 more
openaire   +6 more sources

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Annals of the Rheumatic Diseases, 2023
Objectives To update the EULAR recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. Methods An international Task Force formed the questions for the systematic literature reviews (January 2018–December ...
A. Fanouriakis, M. Kostopoulou, Jeanette Andersen, M. Aringer, Laurent Arnaud, Sang-Cheol Bae, John Boletis, I. Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, R. Furie, D. Gladman, F. Houssiau, L. Inês, D. Jayne, M. Kouloumas, László Kovács, C. Mok, Eric F Morand, Gabriella Moroni, Marta Mosca, J. Mucke, C. Mukhtyar, György Nagy, S. Navarra, Ioannis Parodis, J. Pego-Reigosa, M. Petri, Bernardo A Pons-Estel, M. Schneider, J. Smolen, E. Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y. Teng, A. Tincani, E. Vital, RF van Vollenhoven, Chris Wincup, G. Bertsias, Dimitrios T Boumpas   +41 more
semanticscholar   +1 more source

Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature

Brain Sciences, 2021
(1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies.
Alba Jerez-Lienas, Alexis Mathian, Jenifer Aboab, Isabelle Crassard, Miguel Hie, Fleur Cohen-Aubart, Julien Haroche, Denis Wahl, Ricard Cervera, Zahir Amoura   +9 more
doaj   +1 more source

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

Arthritis & Rheumatology, 2022
To assess the efficacy and safety of deucravacitinib, an oral, selective, allosteric inhibitor of TYK2, in a phase II trial in adult patients with active systemic lupus erythematosus (SLE).
Eric F Morand, M. Pike, J. Merrill, R. V. van Vollenhoven, V. Werth, C. Hobar, N. Delev, V. Shah, B. Sharkey, T. Wegman, I. Catlett, Subhashish Banerjee, S. Singhal   +12 more
semanticscholar   +1 more source

Systemic lupus erythematosus with trisomy X: a case report and review of the literature

Journal of Medical Case Reports, 2022
Background The cause of systemic lupus erythematosus is not completely clear so far, but the prevalence of systemic lupus erythematosus is significantly increased in people with additional X chromosomes.
Fang Luo, Qiao Ye, Jie Shen
doaj   +1 more source

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Arthritis & Rheumatology, 2019
To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
M. Aringer, K. Costenbader, D. Daikh, R. Brinks, M. Mosca, R. Ramsey‐Goldman, J. Smolen, D. Wofsy, D. Boumpas, D. Kamen, D. Jayne, R. Cervera, N. Costedoat-Chalumeau, B. Diamond, D. Gladman, B. Hahn, F. Hiepe, S. Jacobsen, D. Khanna, K. Lerstrøm, E. Massarotti, Joseph Mccune, G. Ruiz‐Irastorza, J. Sánchez-Guerrero, Matthias Schneider, M. Urowitz, G. Bertsias, B. Hoyer, N. Leuchten, C. Tani, S. Tedeschi, Z. Touma, G. Schmajuk, B. Anić, F. Assan, T. Chan, A. Clarke, M. Crow, L. Czirják, A. Doria, W. Graninger, Bernadett Halda-Kiss, S. Hasni, P. Izmirly, M. Jung, G. Kumánovics, X. Mariette, I. Padjen, J. Pego-Reigosa, J. Romero-Díaz, Íñigo Rúa-Figueroa Fernández, R. Seror, G. Stummvoll, Yoshiya Tanaka, M. Tektonidou, C. Vasconcelos, E. Vital, D. Wallace, Ş. Yavuz, Marcus John Beasley, M. Fritzler, R. Naden, T. Dörner, S. Johnson   +63 more
semanticscholar   +2 more sources

Peritonitis as the first presentation of systemic lupus erythematous: a case report

Journal of Medical Case Reports, 2021
Background Systemic lupus erythematosus is an inflammatory disease affecting several organs. Serositis is one of the systemic lupus erythematosus presentations, but peritonitis is a relatively rare presentation.
Zahedin Kheyri, Amirreza Laripour, Moein Ala   +2 more
doaj   +1 more source